Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 15, No 2 (2019) Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... of antiviral therapy on these parameters in patients with viral liver cirrhosis (VLC). Material and methods ..."
 
Vol 13, No 3 (2017) ROLE OF PULMONARY HYPERTENSION IN THE DEVELOPMENT OF CIRRHOTIC CARDIOMYOPATHY Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... of cirrhotic cardiomyopathy.Keywords: heart, рulmonary аrtery, cirrhosis of the liver. ..."
 
Vol 12, No 6 (2016) POSSIBLE CHANGES IN THE CENTRAL HEMODYNAMICS IN PORTAL HYPERTENSION DUE TO LIVER CIRRHOSIS OF VIRAL ETIOLOGY WITH DIFFERENT LEVELS OF CYTOKINES Abstract  similar documents
V. E Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva
"... of central hemodynamics in liver cirrhosis depends on the stage of compensation. The most pronounced systolic ..."
 
Vol 14, No 3 (2018) FEATURES OF HEART LESIONS IN PATIENTS WITH VIRAL LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin
"... of antiviral therapy on certain cardiohemodynamic parameters in patients with viral liver cirrhosis (VLC ..."
 
Vol 10, No 3 (2014) EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... and the liver in patients with viral cirrhosis. Material and methods. In 75 patients with chronic viral ..."
 
Vol 12, No 6 (2016) EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... in patients with chronic viral hepatitis (CVH) and viral liver cirrhosis (VLC). Material and methods. Doppler ..."
 
Vol 14, No 4 (2018) Some Morpho-Functional Changes of the Left Heart in Patients with Viral Liver Cirrhosis Abstract  similar documents
M V. Chistyakova, A. V. Govorin, N. N. Kushnarenko
"... Цель. Изучить влияние вирусного цирроза печени (ВЦП) на некоторые кардиогемодинамические параметры ..."
 
Vol 13, No 2 (2017) ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE Abstract  similar documents
V. I. Podzolkov, N. A. Dragomiretskaya
"... in congestive heart failure, nephrotic syndrome, and portal cirrhosis is considered in the article. Development ..."
 
Vol 13, No 4 (2017) FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION Abstract  similar documents
V. E. Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva
"... regions in viral hepatic cirrhosis A, B, C classes according to Child-Pugh with different serum levels ..."
 
Vol 4, No 4 (2008) CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES Abstract  similar documents
M. N. Mamedov, O. M. Drapkina
"... A number of comorbid patients is increasing significantly. Chronic diffusive liver diseases meet ..."
 
Vol 12, No 4 (2016) Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk Abstract  similar documents
O. M. Drapkina, O. N. Korneeva
"... The problem of non-alcoholic fatty liver disease (NAFLD), which is an independent risk factor ..."
 
Vol 12, No 6 (2016) CURRENT METHODS OF ENDOTHELIAL DYSFUNCTION ASSESSMENT AND THEIR POSSIBLE USE IN THE PRACTICAL MEDICINE Abstract  similar documents
A. V. Shabrov, A. G. Apresyan, A. L. Dobkes, S. U. Ermolov, T. V. Ermolova, S. G. Manasyan, S. V. Serdyukov
"... between endotheliumdependent vasoconstrictor and vasodilating factors or mismatch of the local and central ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... to use statins in patients with cardiovascular diseases and concomitant chronic liver diseases. Analysis ..."
 
Vol 15, No 3 (2019) Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... and nonalcoholic fatty liver disease (NAFLD) or other hepatobiliary diseases, especially in cases when elevated ..."
 
Vol 9, No 2 (2013) STATIN SAFETY REVISITED DATA Abstract  similar documents
O. M. Drapkina
"... Questions of statins use in liver diseases are discussed. Data from clinical studies on statins ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... Aim. To assess the potential of ursodeoxycholic acid (UDCA) in the prevention of liver dysfunction ..."
 
Vol 13, No 5 (2017) NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE Abstract  similar documents
O. M. Drapkina, A. A. Yafarova
"... Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, which ..."
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
"... with cardiovascular diseases and concomitant chronic liver diseases. Material and methods. Сross-sectional ..."
 
Vol 5, No 6 (2009) STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? Abstract  similar documents
I. N. Grigorieva, Y. M. Pozdnyakov
"... Results of combined therapy of gallstone disease (GSD), non-alcoholic fatty liver disease (NAFLD ..."
 
Vol 14, No 4 (2018) Hepatotoxicity of New Oral Anticoagulants Abstract  similar documents
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin
"... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... . The UDCA intake was recommended to all the patients due to the presence of liver and/or bile duct diseases ..."
 
Vol 10, No 5 (2014) CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES Abstract  similar documents
N. A. Dzhaiani
"... pulmonary disease, elderly patients, and concomitant liver diseases). ..."
 
Vol 6, No 1 (2010) SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT Abstract  similar documents
N. A. Jaiani
"... , elderly patients, and concomitant liver diseases). Pharmacoeconomic aspects of lisinopril usage ..."
 
Vol 3, No 4 (2007) THE PECULIARITIES OF CEREBRAL BLOOD FLOW IN PATIENTS WITH CHRONIC HEPATITIS Abstract  similar documents
V. E. Kulikov, B. B. Fishman, A. V. Volkov, G. S. Malyutin, G. I. Shvartsman
"... .Е. Полисиндромность цирроза печени. Великий Новгород: НовГУ; 1999. 4. Левтов А.В., Регирер С.А., Шадрина И ..."
 
Vol 7, No 6 (2011) EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS Abstract  similar documents
V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova
"... . Bifunctional daily blood pressure (BP) and electrocardiogramm monitoring with evaluation of central aortic ..."
 
Vol 10, No 5 (2014) EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova
"... cholesterol target levels by the end of the third month of treatment in 91% of patients. Elevated liver ..."
 
Vol 2, No 4 (2006) DAILY CHANGES OF CENTRAL HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE WITH NIGHT-TIME DYSPNOEA ATTACK Abstract  similar documents
S. A. Dovgolis, I. G. Fomina
"... Aim. To study daily changes of central hemodynamics (CHD) in patients with chronic heart failure ..."
 
Vol 14, No 4 (2018) Influence of Childhood and Adulthood Obesity on Arterial Stiffnes and Central Blood Pressure in Men Abstract  similar documents
O. Yu. Isaykina, V. B. Rozanov, A. A. Alexandrov, E. I. Ivanova, H. S. Pugoeva
"... stiffness, central aortic pressure in the population sample of men 42 to 43 years. Methods. The study ..."
 
Vol 12, No 3 (2016) MEMBRANE BILE ACID RECEPTOR TGR5 - A NEW TARGET IN THE STUDY OF METABOLIC, INFLAMMATORY AND NEOPLASTIC DISEASES Abstract  PDF (Eng)  similar documents
O. M. Drapkina, E. I. Fomicheva
"... with metabolic syndrome, diabetes, obesity, atherosclerosis, liver disease and cancer processes. ..."
 
Vol 13, No 4 (2017) ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION: GENDER DIFFERENCES OF VENTRICULOATRIAL REMODELING WITH PRESERVED EJECTION FRACTION Abstract  similar documents
Zh. D. Kobalava, E. V. Kokhan, G. K. Kiyakbaev, A. A. Shavarov
"... related with central aortic pressures. Many studies have shown gender differences of central pulse wave ..."
 
Vol 11, No 3 (2015) IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Goncharova, E. V. Radaeva
"... speed and diameter of blood vessels in liver were determined by ultrasound Doppler. Cardiac hemodynamics ..."
 
Vol 8, No 1 (2012) URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL  similar documents
S. von Haehling, J. C. Schefold, E. A. Jankowska, J. Springer, A. Vazir, P. R. Kalra, A. Sandek, G. Fauler, T. Stojakovic, M. Trauner, P. Ponikowski, H-D. Volk, W. Doehner, A. J. S. Coats, P. A. Poole-Wilson, S. D. Anker
"... заболеваний печени с холестазом, обладает противовоспалительным и цитопротекторными свойствами и может ..."
 
Vol 14, No 6 (2018) The Situation with Valsartan – Commentary of S.A. Boytsov, Chief Cardiologist of Ministry of Health of Russia for the Central, Urals, Siberian and Far Eastern Federal Districts Abstract  PDF (Eng)  similar documents
artilce Editorial
 
Vol 12, No 3 (2016) NEW METHODS OF ASSESSMENT OF SUBCLINICAL CHANGES IN THE CARDIOVASCULAR SYSTEM IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
Zh. D. Kobalava, Yu. V. Kotovskaya, A. V. Bogomaz
"... : central arterial pressure, reflected wave, left ventricular-arterial interaction, arterial hypertension ..."
 
Vol 14, No 2 (2018) HYPERTENSION AND DIABETES MELLITUS TYPE 2 Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... amlodipine on the parameters of central aortic pressure (CAD) and visceral obesity in patients with arterial ..."
 
Vol 14, No 6 (2018) Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 Abstract  PDF (Eng)  similar documents
V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova
"... on daily monitoring of arterial pressure, central aortic pressure, and arterial stiffness, depending ..."
 
Vol 13, No 1 (2017) THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS Abstract  similar documents
O. M. Drapkina, R. N. Shepel
"... of hematopoiesis or central nervous system. However cobalamin deficiency also affects the state ..."
 
Vol 14, No 5 (2018) Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case Abstract  similar documents
M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov
"... with type 2 diabetes mellitus and liver fibrosis demonstrates a combination of polyvalent risk factors ..."
 
Vol 7, No 5 (2011) COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... ) received generic simvastatin. Initial simvastatin dose was 20 mg daily. Lipid plasma profile, liver enzymes ..."
 
Vol 10, No 1 (2014) CHARACTERISTICS OF RENIN PROFILE AND PARAMETERS OF ARTERIAL STIFFNESS IN PATIENTS WITH PREVIOUSLY UNTREATED HYPERTENSION Abstract  similar documents
O. A. Kravtsova, E. A. Pavlova, Yu. V. Kotovskaya, Zh. D. Kobalava
"... Aim. To study the characteristics of renin profile and parameters of central pulse wave ..."
 
Vol 12, No 4 (2016) Organoprotective effects of serelaxin in patients with severe decompensated heart failure Abstract  similar documents
Z. D. Kobalava, S. V. Villevalde, A. E. Solov'jova, I. A. Merai
"... on the heart, kidneys, liver. 48-hour serelaxin infusion in patient with ischemic cardiomyopathy and severe ..."
 
Vol 10, No 5 (2014) STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE Abstract  similar documents
L. N. Malay
"... даже цирроз печени класс А по классификации Чайль- Пью) терапия статинами безопасна [22]. В ряде ис ..."
 
Vol 10, No 6 (2014) ALCOHOLIC CARDIOMYOPATHY: BASIC ASPECTS OF EPIDEMIOLOGY, PATHOGENESIS AND PHARMACOTHERAPY Abstract  similar documents
A. O. Yusupova
"... желез. Если имеются симптомы, характерные для цирроза печени (пальмарная эритема, желтуха, ас- цит ..."
 
Vol 3, No 1 (2007) DIZZINESS OF ISCHEMIC GENESIS: DESCRIPTION OF VESTIBULAR DISORDERS AND POSSIBILITY OF THERAPY Abstract  similar documents
N. S. Alekseeva
"... Aim. To reveal the peculiarities of peripheral and central vestibular disorders in patients ..."
 
Vol 10, No 5 (2014) USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES Abstract  similar documents
V. R. Abdrakhmanov, N. I. Gaponova, N. F. Plavunov
"... Results of clinical trials devoted to urapidil, antihypertensive drug having central ..."
 
Vol 8, No 5 (2012) URAPIDIL IN THE TREATMENT OF MEDICAL EMERGENCIES CAUSED BY BLOOD PRESSURE INCREASE Abstract  similar documents
N. I. Gaponova, V. R. Abdrakhmanov, S. N. Tereschenko
"... Results of experimental and clinical studies devoted to urapidil combining central ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... with a pronounced vasodilating effect and a long half-life significantly reduces central arterial pressure ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... ) Диализ, креатинин >200 ммоль/л, цирроз печени, билирубин > 2 норм, АСТ/АЛТ>норм S Инсульт (1 балл ..."
 
Vol 4, No 5 (2008) MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM Abstract  similar documents
I. Yu. Torshin, O. A. Gromova
"... - тезируется в печени из аспартата и карбамоилфосфа- та. Пищевыми источниками, богатыми оротовой кис- лотой ..."
 
Vol 8, No 1 (2012) NEW POSSIBILITIES IN HEART FAILURE THERAPY: POTENTIAL OF DRUGS BASED ON URSODEOXYCHOLIC ACID Abstract  similar documents
O. M. Drapkina, O. N. Korneyeva
"... - казателей функции печени: снижение уровней гамма- глутамилтрансферазы, аспарагиновой трансаминазы, рецептора ..."
 
Vol 11, No 3 (2015) ALCOHOL AND HEART RHYTHM DISORDERS Abstract  similar documents
A. O. Yusupova, A. S. Lishuta
"... алкогольным циррозом печени (при этом признаки структурных изменений в сердце отсутствовали) по сравнению с ..."
 
Vol 10, No 6 (2014) «MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION Abstract  similar documents
S. R. Gilyarevskiy
"... ’s status in stable IHD, data about negative effect of heart rate (HR) reduction on the central aortic ..."
 
Vol 14, No 6 (2018) Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding Abstract  PDF (Eng)  similar documents
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
"... with stroke, kidney or liver failure. Data is given on the frequency of the main types of bleeding while ..."
 
Vol 10, No 6 (2014) PROGNOSTIC IMPACT OF COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED HYPONATREMIA IN PATIENTS WITH DECOMPENSATED HEART FAILURE Abstract  similar documents
D. Yu. Shchekochikhin, Ph. Yu. Kopylov, N. L. Kozlovskaya, A. L. Syrkin
"... в легких). Критерии исключения: острый коронарный синдром, цирроз печени, паренхиматозные ..."
 
Vol 14, No 2 (2018) EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, Е. E. Shkolnikova, O. I. Lukina
"... with a decrease in central systolic blood pressure (from 116Ѓ}19 to 106Ѓ}10 mm Hg; p=0.001) and central pulse ..."
 
Vol 5, No 6 (2009) PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES Abstract  PDF (Eng)  similar documents
O. V. Reshetko, N. V. Furman, R. M. Magdeev, Ya. P. Ya.P. Dovgalevskiy
"... discharged from cardiologic departments of several central district hospitals (CDH) of Saratov region ..."
 
Vol 14, No 4 (2018) Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome Abstract  similar documents
O. M. Drapkina, O. E. Shirobokikh
"... ), короткоцепочечных жирных кислот (КЦЖК) и вторичных желчных кислот (ЖК). ТМАО (продукт окисления в печени ..."
 
Vol 12, No 4 (2016) Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... ) печеночной пожилым с циррозом с сердечной недостаточности пациентам печени недостаточ- ностью Лекарственные ..."
 
Vol 3, No 4 (2007) EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS Abstract  similar documents
A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova
"... influence on central and peripheral hemodynamics. Material and methods. 60 patients with AH of I-II stage ..."
 
Vol 7, No 2 (2011) THE EYE — MIRROR OF CARDIOVASCULAR DISORDER. RELATIONSHIP OF THE RETINA FUNCTIONAL STATE AND THE HYPERTENSION SEVERITY Abstract  similar documents
V. S. Zadionchenko, T. V. Adasheva, A. M. Shamshinova, M. A. Arakelyan
"... . These changes were located in the area of central retinal artery (paramacular area) and area of choroidal blood ..."
 
Vol 4, No 1 (2008) COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
A. R. Kiselyov, V. I. Gridnev, O. V. Shevchenko, O. M. Posnenkova, A. N. Strunina, V. A. Schwarz, Ja. P. Dovgalevsky
"... effects on the central mechanisms of autonomic heart regulation and HRV, though atenolol effect ..."
 
Vol 14, No 4 (2018) Takotsubo Syndrome: Contemporary Views on the Pathogenesis, Prevalence and Prognosis Abstract  similar documents
A. S. Shilova, A. O. Shmotkina, A. A. Yafarova, M. Yu. Gilyarov
"... appear to play a central role in the pathophysiology of TTS. However, it is conceivable that some people ..."
 
Vol 14, No 5 (2018) Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria Abstract  similar documents
Yu. N. Belenkov, E. V. Privalova, V. Y. Kaplunova, V. Y. Zektser, N. N. Vinogradova, I. S. Ilgisonis, G. A. Shakaryants, M. V. Kozhevnikova, A. S. Lishuta
"... , myocardial infarction, cerebral stroke  and  diabetes mellitus. The most dangerous is the central obesity ..."
 
Vol 13, No 3 (2017) ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) Abstract  PDF (Eng)  similar documents
O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov
"... and central pressure were significantly higher in the group with hypertension (HT). Risk of HT development ..."
 
Vol 6, No 4 (2010) RUSSIAN EXPERTS’ CONSENSUS ON METABOLIC SYNDROME PROBLEM IN THE RUSSIAN FEDERATION: DEFENITION, DIAGNOSIS CRITERIA, PRIMARY PREVENTION AND TREATMENT Abstract  similar documents
N. M. Achmegdanov, S. A. Butrusova, I. I. Dedov, L. A. Zvenigorodskaya, O. A. Kislyak, O. A. Koshelskaya, I. V. Kuznecova, V. V. Kuharchuk, A. Yu. Litvin, I. V. Medvedeva, A. M. Mkrtumyan, V. B. Mychka, D. V. Nebieridze, S. V. Nedogoda, R. G. Oganov, M. Yu. Ogarkov, N. B. Perepech, V. I. Podzolkov, V. P. Smetnik, A. V. Susekov, V. N. Titov, T. V. Tyurina, A. N. Fursov, V. N. Hirmanov, I. E. Chazova, I. I. Chukaeva, M. V. Shestakova, A. T. Shubina
"... воротную вену. В печени большое количество НЭЖК подавляет чувствитель- ность к инсулину ферментов гликолиза ..."
 
Vol 11, No 5 (2015) A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation Abstract  similar documents
E. I. Emelina, G. E. Gendlin
"... крови, его биодоступность не из- меняется у пациентов с циррозом печени, не возникает необходимости ..."
 
Vol 10, No 4 (2014) NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... Баллы Артериальная гипертензия (систолическое АД>160 мм рт.ст.) 1 Нарушенная функция печени (тяжелое ..."
 
Vol 3, No 2 (2007) CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS Abstract  similar documents
V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina
"... Aim. To evaluate intensity of endothelial dysfunction, processes of apoptosis, state of central ..."
 
Vol 2, No 2 (2006) THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL Abstract  similar documents
Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto
"... suggest that in hypertensive patients central inhibition of sympathetic drive can produce favorable ..."
 
Vol 2, No 2 (2006) PECULIARITIES OF ARTERIAL HYPERTENSION DIAGNOSIS AND SECONDARY PREVENTION ACCORDING TO PHYSICIANS INTERVIEWING Abstract  similar documents
N. S. Oganisyan, N. A. Dmitrieva, A. M. Kochetkov, S. Y. Martsevich
"... medicines (antagonists of angiotensin-II receptors, central acting medicines) made about 1% of share. When ..."
 
Vol 5, No 3 (2009) REPERFUSION THERAPY IN ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION Abstract  similar documents
A. L. Alyavi, B. A. Alyavi
"... ) on the central and intracardiac hemodynamics in patients with acute coronary syndrome (ACS) with ST segment ..."
 
Vol 13, No 5 (2017) AGE AND GENDER PECULIARITIES OF BLOOD LIPIDS IN URBAN RESIDENTS (CROSS-SECTIONAL STUDY RESULTS) Abstract  similar documents
S. A. Urazgildeeva, M. Yu. Nizhegorodcev, P. S. Sadovnikov, A. Yu. Olkhovik, D. Yu. Nokhrin, M. V. Muzalevskaya, I. V. Shugurova, D. G. Malenkovskaya, A. V. Tregubov, V. S. Gurevich
"... -livers. Low level of HDL-C was observed in 24.46% of the total number of samples in men and in 17 ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... to atorvastatin and at the same time the rosuvastatin group  was safer regarding liver enzymes elevation, p<0 ..."
 
Vol 10, No 3 (2014) THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW Abstract  similar documents
D. A. Napalkov
"... повы- шение уровня трансаминаз далеко не всегда ассо- циировано с нарушением функционирования печени ..."
 
Vol 12, No 6 (2016) INDEX OF THE PAPERS PUBLISHED IN THE “RATIONAL PHARMACOTHERAPY IN CARDIOLOGY” JOURNAL IN 2016 Abstract  similar documents
article editorial
"... хроническим вирусным ге- патитом и циррозом печени – 6, 681 В.Е. Куликов, Емелина Т.А. Емелина, О.Г. Казакова ..."
 
Vol 6, No 3 (2010) THE SPECIFIC FEATURES OF HEART AND VESSELS REMODELING IN PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH LISINOPRIL DURING 6 MONTHS Abstract  similar documents
N. A. Kosheleva, A. P. Rebrov
"... печени или уже имеющим поражение этого органа (гепатит, цирроз), показаны препараты, которые не ..."
 
Vol 14, No 3 (2018) COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU Abstract  similar documents
S. V. Povetkin, O. V. Levashova, V. I. Ghicavii, N. G. Batchinschi, L. A. Pjdgurschi, L. M. Turca
"... .7 and 13.6%, respectively. The additional antihypertensives, including central action drugs and alpha ..."
 
Vol 5, No 1 (2009) ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL Abstract  similar documents
V. I. Podzolkov, K. K. Osadchy
"... . Большинство ИАПФ является пролекарствами, ме- таболизирующимися в печени с образованием ак- тивных метаболитов ..."
 
Vol 7, No 2 (2011) PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? Abstract  similar documents
I. V. Zotova, D. A. Zateyshchikov
"... Заболевания печени Цирроз печени, уровни АЛТ или АСТ≥2 ВГН, уровень альбумина < 3,6 г/л 1 Заболевания почек ..."
 
Vol 4, No 3 (2008) HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA Abstract  similar documents
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova
"... функцио- нальная недостаточность во многом определяется на- рушением процессов глюконеогенеза в печени и ..."
 
Vol 11, No 6 (2015) There is a risk of kidney damage, while saving the heart (case report) Abstract  similar documents
V. A. Batalin, O. M. Polyakova, M. V. Batalina
"... , острая сердечная недостаточность, ХСН, цирроз печени, множественная миелома, стенозирую- щие поражения ..."
 
Vol 7, No 6 (2011) NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina
"... , пересадка почки или ХПН с уровнем креатинина крови >200 мкмоль/л) или печени (цирроз или билирубин крови ..."
 
Vol 9, No 3 (2013) EPICARDIAL FAT: A STRIKER OR A SPARE? Abstract  similar documents
O. M. Drapkina, O. N. Korneeva, Yu. S. Drapkina
"... ): 3–5). 4. Drapkina O.M., Tutnov D.A. Features of treatment of hypertension in patients with liver ..."
 
Vol 9, No 5 (2013) LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY Abstract  similar documents
O. I. Afanasieva, S. N. Pokrovsky
"... , направ- ленные на блокировку синтеза белков клеток печени, участвующих в развитии дислипидемий различного ..."
 
Vol 10, No 6 (2014) INDEX OF THE PAPERS PUBLISHED IN THE “RATIONAL PHARMACOTHERAPY IN CARDIOLOGY” JOURNAL IN 2014 Abstract  similar documents
"... противовирусной терапии на гемодинамику сердца и печени у больных с вирусным циррозом – 3, 299 Т.Й. Веков ..."
 
Vol 2, No 4 (2006) THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
E. V. Konstantinova, A. V. Magnitskyi, N. A. Schostak
"... (декомпенсированный цирроз печени, острый гепатит, выраженная портальная ги- пертензия), обострение язвенной болезни ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... , severe and decompensated DM, acute or exacerbated chronic liver and kidney diseases, acute infection ..."
 
Vol 9, No 6 (2013) DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi
"... kidney and liver diseases; anemia, obesity of III degree, any thyroid dysfunction and on- cological ..."
 
Vol 9, No 4 (2013) THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev
"... биотрансформации в печени при участии изоферментов системы цитохромов P-450. На первом этапе, образуется 2-оксо ..."
 
Vol 6, No 5 (2010) INFILTRATIVE CARDIOVASCULARDISEASES: CARDIOMYOPATHIES THAT LOOK ALIKE Abstract  similar documents
J.B. Seward, G. Casclang-Verzosa, N. S. Chipigina
"... функции печени, слабость и сонли- вость, гиперпигментация кожи, сахарный диабет, артралгии, у мужчин им ..."
 
Vol 12, No 1 (2016) Gut microbiota – a new companion on the path of cardiovascular diseases progression: surprising roles of long-time neighbors Abstract  similar documents
O. M. Drapkina, A. N. Kaburova
"... microbiota and non-alcoholic fatty liver disease: new insights. Clin Microbiol Infect 2013;19(4):338-48. 13 ..."
 
Vol 4, No 5 (2008) CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE ROLE OF SYSTEMIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION Abstract  similar documents
D. A. Poddubnyy, A. P. Rebrov
"... периферического атеросклероза, ак- тивного гепатита, цирроза печени, поражения почек с развитием хронической ..."
 
Vol 3, No 2 (2007) VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY Abstract  similar documents
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes
"... - Факторы риска HEMORR2HAGES, (баллы) Объяснение Патология печени (1) Заболевания печени: цирроз печени ..."
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... , катализирующий синтез эндогенного холе- стерина в печени и дистальных отделах тонкой кишки, - считаются основными ..."
 
Vol 12, No 6 (2016) ROLE OF NON-DRUG THERAPIES OF METABOLIC SYNDROME: CHALLENGES AND PROSPECTS Abstract  similar documents
S. N. Strelkova, K. V. Ovsyannicov, N. I. Utkina
"... fatty liver dis- ease. Rossiyskie Meditsinskie Vesti. 2012;17(3):19-24. (In Russ.) [Драпкина О ..."
 
Vol 9, No 2 (2013) ROLE OF INSULIN RESISTANCE AND ITS CORRECTION IN THE PROCESS OF VASCULAR AGING Abstract  similar documents
E. N. Dudinskaya, O. N. Tkacheva, I. D. Strazhesko, D. U. Akasheva
"... . Неэндокринная ИР: цирроз печени, уремия, эс- сенциальная АГ, ревматоидный артрит, раковая кахек- сия, сердечная ..."
 
Vol 6, No 5 (2010) NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION Abstract  similar documents
O. D. Ostroumova, E. A. Smolyarchuk, I. V. Khvorostyanaya
"... дольше. Кроме того, при на- рушении функции печени (циррозы печени, тяжелые гепатиты и т ..."
 
Vol 11, No 4 (2015) TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE Abstract  similar documents
V. A. Korneva, T. Yu. Kuznetsova, E. S. Karpova, K. I. Rupasova
"... ,7%), повышенный уровень трансаминаз (46,2%), цирроз печени (23,1%), в 20,4% случаев причина была не- известна ..."
 
Vol 8, No 2 (2012) RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS Abstract  similar documents
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova
"... заболевания; цирроз печени; портальная ги- пертония; варикозное расширение вен пищевода; прием нестероидных ..."
 
1 - 100 of 407 Items 1 2 3 4 5 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)